Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Cardiovascular+Disease%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
/vufind/Search/Results?lookfor=%22Cardiovascular+Disease%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
Search /vufind/Search2/Results?lookfor=%22Cardiovascular+Disease%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22
PubPharm (4.559)
1
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia : A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study of Olezarsen (ISIS 678354) in Patients With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), or With Severe Hypertriglyceridemia
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Colchicine and Inflammation in Aortic Stenosis : Does Colchicine Reduce Progression of Aortic Valve Stenosis?
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany : A Randomized, Double-blind, Placebo-controlled, Multicenter Trial Assessing the Reduction of the Rate of Lipoprotein Apheresis After Treatment With Pelacarsen (TQJ230) Compared to Placebo in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease Undergoing Weekly Lipoprotein Apheresis in Germany
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels : The Cardiovascular Safety and Efficacy of Cagrilintide 2.4 mg s.c. in Combination With Semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) Once-weekly in Participants With Established Cardiovascular Disease
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation : ZEUS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Participants With Established Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease and Systemic Inflammation
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) : A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) Who Have Established Atherosclerotic Cardiovascular Disease or Are at Risk for a First Cardiovascular Event - ACCLAIM-Lp(a)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES) : A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and the Decline in Kidney Function in Participants With Body Mass Index ≥27 kg/m^2 and Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. : A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine : The Canadian Study of Arterial Inflammation in Patients With Diabetes and Recent Vascular Events: EvaluatioN of Colchicine Effectiveness (CADENCE)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients : A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[456]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 3
Medienart
4.559
Aufsätze
4.559
E-Artikel
4.559
E-Ressourcen
Zeitschriftentitel
4.384
WHO International Clinical Trials Registry Plat...
175
ClinicalTrials.gov
Thema
4.559
610
Phase: Phase 3
4.559
Study Type: Interventional
2.864
Recruitment Status: Not yet recruiting
1.352
Recruitment Status: Authorised-recruitment may ...
175
Cardiovascular Diseases
134
Recruitment Status: Completed
70
Medical Condition: Acute heart failure;Therapeu...
62
Recruitment Status: Recruiting
60
Medical Condition: Pulmonary Arterial Hypertens...
42
Medical Condition: Transthyretin Amyloidosis wi...
40
Medical Condition: Type II Diabetes Mellitus an...
36
Medical Condition: Acute Coronary Syndrome MedD...
36
Medical Condition: Hypertrophic Cardiomyopathy ...
34
Medical Condition: Pulmonary arterial hypertens...
34
Medical Condition: atherosclerosis MedDRA versi...
34
Medical Condition: pulmonary arterial hypertens...
32
Medical Condition: Cardiovascular diseases MedD...
32
Medical Condition: Left ventricular dysfunction...
30
Medical Condition: Hypertension MedDRA version:...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.642
2020-
1.907
2010-2019
10
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
4.511
Englisch
34
Unbestimmt
6
Französisch
4
Italienisch
2
Tschechisch
2
Spanisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...